Published prognostic scores have limitations in prediction of long term survival after stereotactic radiotherapy for brain metastases. Moreover, no validated tools are available for prediction of local failure. The value of radiomics is evaluated in this perspective.
Sensitivity is low for prediction of long term survival of currently available prognostic scores for brain metastases. First the current clinical models will be optimized with a new prognostic model and nomogram. Radiomics is a tool to analyze tumor characteristics based on CT and MR images. These tumor characteristics may reflect tumor biology and outcome. Therefore it is investigated if radiomics improves prediction of long term survival after stereotactic radiotherapy for brain metastases. Moreover, the predictive value of radiomics for local failure is investigated.
Study Type
OBSERVATIONAL
Enrollment
155
Maastro Clinic
Maastricht, Netherlands
Sensitive value of 12 months survival after stereotactic radiotherapy for brain metastases with radiomics
Sensitivity of 12 months survival after stereotactic radiotherapy for brain metastases with radiomics. Radiomics is a tool to analyze tumor characteristics based on CT and MR images.
Time frame: 1 year
Sensitive value of 12 months local failure after stereotactic radiotherapy for brain metastases with radiomics
Sensitivity of 12 months local failure after stereotactic radiotherapy for brain metastases with radiomics. Radiomics is a tool to analyze tumor characteristics based on CT and MR images.
Time frame: 1 year
Specificity of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Specificity of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Time frame: 1 year
Positive predictive value of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Positive predictive value of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Time frame: 1 year
Negative predictive value of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Negative predictive value of 12 months survival and local failure after stereotactic radiotherapy for brain metastases with radiomics.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.